Risk of breast cancer following low-dose radiation exposure.

Risk of breast cancer following radiation exposure was studied, based on surveys of tuberculosis patients who had multiple fluoroscopic examinations of the chest, mastitis patients given radiotherapy, and atomic bomb survivors. Analysis suggests that the risk is greatest for persons exposed as adolescents, although exposure at all ages carries some risk. The dose-response relationship was consistent with linearity in all studies. Direct evidence of radiation risk at doses under 0.5 Gy (50 rad) is apparent among A-bomb survivors. Fractionation does not appear to diminish risk, nor does time since exposure (even after 45 years of observation). The interval between exposure and the clinical appearance of radiogenic breast cancer may be mediated by hormonal or other age-related factors but is unrelated to dose. Age-specific absolute risk estimates for all studies are remarkably similar. The best estimate of risk among American women exposed after age 20 is 6.6 excess cancers/10(4) WY-G-Y (10(6) WY-rad).

[1]  R. Mole.  Ionizing radiation as a carcinogen: practical questions and academic pursuits The Silvanus Thompson Memorial Lecture delivered at The British Institute of Radiology on April 18, 1974. , 1975, The British journal of radiology.

[2]  A. Upton.  Radiobiological effects of low doses. Implications for radiological protection. , 1977, Radiation Research.

[3]  J. Fraumeni,et al.  Breast carcinoma following radiotherapy of metastatic Wilms' tumor , 1977, Cancer.

[4]  J. Boice,et al.  Estimation of breast doses and breast cancer risk associated with repeated fluoroscopic chest examinations of women with tuberculosis. , 1978, Radiation research.

[5]  C. W. Mays,et al.  Leukemia risk from neutrons. , 1978, Health physics.

[6]  P. Armitage.  Tests for Linear Trends in Proportions and Frequencies , 1955 .

[7]  S. Thier.  Breast cancer screening: a view from outside the controversy. , 1977, New England Journal of Medicine.

[8]  R. Lester.  Risk versus benefit in mammography. , 1977, Radiology.

[9]  B. Pasternack,et al.  Breast neoplasms in women treated with x-rays for acute postpartum mastitis. , 1977, Journal of the National Cancer Institute.

[10]  Albrecht M. Kellerer,et al.  THEORY OF DUAL RADIATION ACTION. , 1972 .

[11]  E. Cronkite,et al.  Studies on radiation-induced mammary gland neoplasia in the rat. VI. The effect of changes in thyroid function, ovarian function, and pregnancy. , 1962, Radiation research.

[12]  J. A. Myrden,et al.  Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis. , 1969, Canadian Medical Association journal.

[13]  H. F. Iknayan.  Carcinoma associated with irradiation of the immature breast. , 1975, Radiology.

[14]  S. Tokuoka,et al.  Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. , 1979, Journal of the National Cancer Institute.

[15]  R. Monson,et al.  Breast cancer in women after repeated fluoroscopic examinations of the chest. , 1977, Journal of the National Cancer Institute.

[16]  G. Beebe,et al.  Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. , 1977, Journal of the National Cancer Institute.

[17]  B. Mattsson,et al.  Breast cancer following irradiation of the breast , 1977, Cancer.

[18]  A. Kellerer,et al.  The validity of risk estimates of leukemia incidence based on Japanese data. , 1974, Radiation research.

[19]  S. Shapiro,et al.  Evidence on screening for breast cancer from a randomized trial , 1977, Cancer.

[20]  W. S. Maxfield,et al.  The synergism between radiation and estrogen in the production of mammary cancer in the rat. , 1971, Cancer research.

[21]  C. Shellabarger.  Modifying factors in rat mammary gland carcinogenesis , 1975 .

[22]  R. Doll,et al.  Late effects of x irradiation in patients treated for metropathia haemorrhagica. , 1976, The British journal of radiology.

[23]  B. Macmahon,et al.  Etiology of human breast cancer: a review. , 1973, Journal of the National Cancer Institute.